Calsarcin-1 modulates the muscle LIM protein/Z-disc complex mechanosensing in familial hypertrophic cardiomyopathy

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disease mainly caused by sarcomeric mutations. The Z-disc is a critical mechanosensory interface linking sarcomeric stress to biochemical signaling, yet the role of calsarcin-1 in maintaining Z-disc integrity remains unclear. Patient-specific iPSC-CM-based engineered heart tissues (EHTs) are being developed for disease modeling and drug screening; however, the loading conditions to recapitulate pathological mechanical stress remain underdeveloped. METHODS: HCM patient heart, three patient-specific iPSC lines (MLP-W4R;MYH7-R723C, MYH7-R663H, and MYBPC3-V321M), derived cardiomyocytes (iPSC-CMs), and engineered heart tissues (EHTs) were employed. Calsarcin-1 expression was assessed, and its role in MLP/Z-disc mechanosensing was investigated through gain- and loss-of-function approaches. An EHT bioreactor was developed to recapitulate HCM-associated elevated afterload, electrical pacing, and cyclic mechanical loading; isogenic wild type and MLP-W4R iPSC lines were generated by genome editing. Calsarcin-1 treatment to rescue the hypertrophic phenotype of isogenic (Iso) MLP-W4R iPSC-CM-EHTs was evaluated. RESULTS: Calsarcin-1 was markedly downregulated in myocardium from an HCM proband carrying heterozygous MLP-W4R and MYH7-R723C variants, as well as in patient-specific iPSC-CMs and EHTs, accompanied by marked upregulation of the hypertrophic markers atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP). Ectopic expression of calsarcin-1 via viral infection in MLP-W4R;MYH7-R723C iPSC-CMs stabilized the MLP/Z-disc machinery and reversed hypertrophy in all three patient-specific iPSC-CMs (MLP-W4R;MYH7-R723C, MYH7-R663H, and MYBPC3-V321M). Knockdown of calsarcin-1 attenuated the rescue effect of MLP overexpression in MLP-W4R;MYH7-R723C iPSC-CMs. Isogenic wild type and MLP-W4R iPSCs were generated by correcting mutations in MLP-W4R;MYH7-R723C iPSCs. Moreover, we developed a 3D-EHT bioreactor system that integrates controlled mechanical loading and electrical pacing to recapitulate the elevated afterload and cyclic mechanical stress characteristic of HCM. The additional mechanical resistance imposed by high afterload prolongs TTP and RT50 and increases the normalized force-time integral (nFTI), suggesting that excessively high afterload drives pathological remodeling in IsoMLP-W4R-iPSC-CM-EHTs. More importantly, calsarcin-1 significantly rescued both systolic and diastolic dysfunction of IsoMLP-W4R-iPSC-CM-EHTs exposed to pathological high afterload. CONCLUSIONS: Calsarcin-1 is a nodal regulator of pathological cardiac remodeling that restores MLP/Z-disc mechanosensing. A patient-derived EHT bioreactor model recapitulating pathological HCM loading identifies calsarcin-1 as a potential therapeutic target.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.15.766848
Primary Topic
Cardiomyopathy and Myosin Studies
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Calsarcin-1 modulates the muscle LIM protein/Z-disc complex mechanosensing in familial hypertrophic cardiomyopathy

Marie Hoareau, Lixia Yue, Yibing Qyang, Saba Fooladi et al.
2 links
bioRxiv (Cold Spring Harbor Laboratory)
Cardiomyopathy and Myosin Studies
preprint

Calsarcin-1 modulates the muscle LIM protein/Z-disc complex mechanosensing in familial hypertrophic cardiomyopathy

Marie Hoareau, Lixia Yue, Yibing Qyang, Saba Fooladi, Muhammad Riaz, Yongbo Lu, Xianmu Li, Qinzhe Xing, Stuart G. Campbell, Hangqi Luo, Xin Li, Yufeng Liu, Ilhan Gokhan, Jinkyu Park, Thomas Blum, Xia Li
preprint en

Abstract

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disease mainly caused by sarcomeric mutations. The Z-disc is a critical mechanosensory interface linking sarcomeric stress to biochemical signaling, yet the role of calsarcin-1 in maintaining Z-disc integrity remains unclear. Patient-specific iPSC-CM-based engineered heart tissues (EHTs) are being developed for disease modeling and drug screening; however, the loading conditions to recapitulate pathological mechanical stress remain underdeveloped. METHODS: HCM patient heart, three patient-specific iPSC lines (MLP-W4R;MYH7-R723C, MYH7-R663H, and MYBPC3-V321M), derived cardiomyocytes (iPSC-CMs), and engineered heart tissues (EHTs) were employed. Calsarcin-1 expression was assessed, and its role in MLP/Z-disc mechanosensing was investigated through gain- and loss-of-function approaches. An EHT bioreactor was developed to recapitulate HCM-associated elevated afterload, electrical pacing, and cyclic mechanical loading; isogenic wild type and MLP-W4R iPSC lines were generated by genome editing. Calsarcin-1 treatment to rescue the hypertrophic phenotype of isogenic (Iso) MLP-W4R iPSC-CM-EHTs was evaluated. RESULTS: Calsarcin-1 was markedly downregulated in myocardium from an HCM proband carrying heterozygous MLP-W4R and MYH7-R723C variants, as well as in patient-specific iPSC-CMs and EHTs, accompanied by marked upregulation of the hypertrophic markers atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP). Ectopic expression of calsarcin-1 via viral infection in MLP-W4R;MYH7-R723C iPSC-CMs stabilized the MLP/Z-disc machinery and reversed hypertrophy in all three patient-specific iPSC-CMs (MLP-W4R;MYH7-R723C, MYH7-R663H, and MYBPC3-V321M). Knockdown of calsarcin-1 attenuated the rescue effect of MLP overexpression in MLP-W4R;MYH7-R723C iPSC-CMs. Isogenic wild type and MLP-W4R iPSCs were generated by correcting mutations in MLP-W4R;MYH7-R723C iPSCs. Moreover, we developed a 3D-EHT bioreactor system that integrates controlled mechanical loading and electrical pacing to recapitulate the elevated afterload and cyclic mechanical stress characteristic of HCM. The additional mechanical resistance imposed by high afterload prolongs TTP and RT50 and increases the normalized force-time integral (nFTI), suggesting that excessively high afterload drives pathological remodeling in IsoMLP-W4R-iPSC-CM-EHTs. More importantly, calsarcin-1 significantly rescued both systolic and diastolic dysfunction of IsoMLP-W4R-iPSC-CM-EHTs exposed to pathological high afterload. CONCLUSIONS: Calsarcin-1 is a nodal regulator of pathological cardiac remodeling that restores MLP/Z-disc mechanosensing. A patient-derived EHT bioreactor model recapitulating pathological HCM loading identifies calsarcin-1 as a potential therapeutic target.

bioRxiv (Cold Spring Harbor Laboratory)
University of Connecticut (US), Yale University (US), UConn Health (US)
National Institutes of Health
Good health and well-being
Cardiomyopathy and Myosin Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon